Hilary Fairbrother, MD, MPH, FACEP
McGovern School of Medicine
University of Texas Health Houston
Department of Emergency Medicine
Vice Chair of Education
Houston, TX
Twitter: @hilaryfair
Objectives
- Review the laboratory values needed to use the PECARN Clinical Decision Rule to identify neonates with serious SBI
- Discuss and review the recent validation study by Velasco et. Al
- Evaluate the PECARN Decision Rule for the febrile neonate
Outline
- Define the PECARN Clinical Decision rule to identify SBI in the febrile neonate
- Review different laboratory values necessary
- Give a clinical example
- Explain the Velasco validation study and its importance
- Is this validation study “valid?”
- How do their conclusions differ?
- Discuss what is an acceptable miss rate in the neonatal population
- Contrast to the complication rate of SBI rule out procedures
- LP
- Urine cath
- Phlebotomy
- Abx exposure
- Hospital stay
- In conclusion, is this CDR ready for widespread use?
- Contrast to the complication rate of SBI rule out procedures
Post Peer Reviewed By: Salim R. Rezaie, MD (Twitter: @srrezaie)
The post Rebellion21: The Pyretic Neonate – A Cautionary Tale for Decision-Making Rules via Hilary Fairbrother, MD appeared first on REBEL EM - Emergency Medicine Blog.